Cerus (CERS) Gross Margin (QoQ) (2010 - 2026)

Cerus (CERS) Gross Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Cerus 600.87 Mn 520.44 Mn 27.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,695.00
Dec 31, 2025 30,467.00
Sep 30, 2025 396,493.00
Jun 30, 2025 -424,948.00
Mar 31, 2025 -860.00
Dec 31, 2024 281,482.00
Sep 30, 2024 -277,959.00
Jun 30, 2024 -2,327.00
Mar 31, 2024 -3,333.00
Dec 31, 2023 1.02 Mn
Sep 30, 2023 -1.02 Mn
Jun 30, 2023 5,249.00
Mar 31, 2023 -8,714.00
Dec 31, 2022 25,038.00
Sep 30, 2022 -21,272.00
Jun 30, 2022 7,402.00
Mar 31, 2022 -10,509.00
Dec 31, 2021 27,747.00
Sep 30, 2021 -18,989.00
Jun 30, 2021 1,019.00